Dendritic cell vaccines based on immunogenic cell death elicit danger signals and T cell–driven rejection of high-grade glioma

The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data

Cerami, E., Gao, J., Dogrusoz, U., Gross, B. E., Sumer, S. O., Aksoy, B. A., Jacobsen, A., Byrne, C. J., Heuer, M. L., Larsson, E., et al. (2012) · Cancer Discovery · doi:10.1158/2159-8290.cd-12-0095 · Cited by 17,455

The cancer genome atlas pan-cancer analysis project

The Cancer Genome Atlas Research Network, Weinstein, J. N., Collisson, E. A., Mills, G. B., Shaw, K. R. M., Ozenberger, B. A., Ellrott, K., Shmulevich, I., Sander, C., & Stuart, J. M. (2013) · Nature Genetics · doi:10.1038/ng.2764 · Cited by 9,092

Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial

Stupp, R., Hegi, M. E., Mason, W. P., van den Bent, M. J., TAPHOORN, M. J. B., Janzer, R. C., Ludwin, S. K., Allgeier, A., Fisher, B., Bélanger, K., et al. (2009) · The Lancet Oncology · doi:10.1016/s1470-2045(09)70025-7 · Cited by 7,980

Comprehensive genomic characterization defines human glioblastoma genes and core pathways

The Cancer Genome Atlas Research Network (2008) · Nature · doi:10.1038/nature07385 · Cited by 7,735

The Somatic Genomic Landscape of Glioblastoma

Brennan, C. W., Verhaak, R. G. W., McKenna, A., Campos, B., Noushmehr, H., Salama, S. R., Zheng, S., Chakravarty, D., Sanborn, J. Z., Berman, S. H., et al. (2013) · Cell · doi:10.1016/j.cell.2013.09.034 · Cited by 5,016

The immune contexture in human tumours: impact on clinical outcome

Fridman, W. H., Pagès, F., Sautès-Fridman, C., & Galon, J. (2012) · Nature reviews. Cancer · doi:10.1038/nrc3245 · Cited by 4,981

Spatiotemporal Dynamics of Intratumoral Immune Cells Reveal the Immune Landscape in Human Cancer

Bindea, G., Mlecnik, B., Tosolini, M., Kirilovsky, A., Waldner, M. J., Obenauf, A. C., Angell, H. K., Fredriksen, T., Lafontaine, L., Berger, A., et al. (2013) · Immunity · doi:10.1016/j.immuni.2013.10.003 · Cited by 4,455

Immunogenic Cell Death in Cancer Therapy

Kroemer, G., Galluzzi, L., Kepp, O., & Zitvogel, L. (2013) · Annual Review of Immunology · doi:10.1146/annurev-immunol-032712-100008 · Cited by 3,303

Calreticulin exposure dictates the immunogenicity of cancer cell death

Obeid, M., Tesniere, A., Ghiringhelli, F., Fimia, G. M., Apetoh, L., Perfettini, J.-L., Castedo, M., Mignot, G., Panaretakis, T., Casares, N., et al. (2007) · Nature Medicine · doi:10.1038/nm1523 · Cited by 3,216

The prognostic landscape of genes and infiltrating immune cells across human cancers

Gentles, A. J., Newman, A. M., Liu, C. L., Bratman, S. V., Feng, W., Kim, D., Nair, V. S., Xu, Y., Khuong, A., Hoang, C. D., et al. (2015) · Nature Medicine · doi:10.1038/nm.3909 · Cited by 3,163

A Novel Dendritic Cell-Based Vaccination Protocol to Stimulate Immunosurveillance of Aggressive Cancers

Nigro, A., Montico, B., Casolaro, V., & Col, J. D. (2018) · Methods in molecular biology · doi:10.1007/978-1-4939-8885-3_22 · Cited by 10

Research trends and hotspots in prostate cancer associated exosome: a bibliometric analysis

Zhu, Z., Zhou, Y., Li, H., Xu, W., Wang, T., Liu, J., & Jiang, H. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1270104 · Cited by 11

An Integrated Modular Vaccination System for Spatiotemporally Separated Perioperative Cancer Immunotherapy

Gao, F., Liu, X., Ma, Z., Tang, M. S., Tang, Z., Wu, J., Luo, M., Tang, Y., Wang, X., Wang, B., et al. (2025) · Advanced Materials · doi:10.1002/adma.202418322 · Cited by 9

Targeting autocrine retinoic acid signaling by ALDH1A2 inhibition enhances antitumor dendritic cell vaccine efficacy

Fang, C., Esposito, M., Hars, U., Byrne, R. T., Song, B., Huang, J., Roichman, A., Shue, L., Cheng, X., Proudfoot, J., et al. (2026) · Nature Immunology · doi:10.1038/s41590-025-02376-4 · Cited by 9

Fusions of Tumor-derived Endothelial Cells with Dendritic Cells Induces Antitumor Immunity

Huang, Y., Mao, Q., He, J., Su, J., Peng, Y., Liang, W. H., Hu, Z., Zhou, S., Lü, X., & Zhao, Y. (2017) · Scientific Reports · doi:10.1038/srep46544 · Cited by 9

Cyclic Amplification of the Afterglow Luminescent Nanoreporter Enables the Prediction of Anti‐cancer Efficiency

Wang, Y., Song, G., Liao, S., Qin, Q., Zhao, Y., Shi, L., Guan, K., Gong, X., Wang, P., Yin, X., et al. (2021) · Angewandte Chemie · doi:10.1002/ange.202104127 · Cited by 8

E3L and F1L Gene Functions Modulate the Protective Capacity of Modified Vaccinia Virus Ankara Immunization in Murine Model of Human Smallpox

Volz, A., Jany, S., Freudenstein, A., Lantermann, M., Ludwig, H., & Sutter, G. (2018) · Viruses · doi:10.3390/v10010021 · Cited by 8

Breaking the Resistance: Photodynamic Therapy in Cancer Stem Cell-Driven Tumorigenesis

Rajan, S. S., Merlin, J. P. J., & Abrahamse, H. (2025) · Pharmaceutics · doi:10.3390/pharmaceutics17050559 · Cited by 6

Overcoming resistant cancerous tumors through combined photodynamic and immunotherapy (photoimmunotherapy)

Kah, G., & Abrahamse, H. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1633953 · Cited by 7

Bibliometric analysis of photodynamic therapy and immune response from 1989–2023

Fan, W., Tang, J., Tang, S., Lin, Z., Li, M., Zhang, Z., & Wu, D. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1299253 · Cited by 6

Immune response induced by hematoporphyrin derivatives mediated photodynamic therapy: Immunogenic cell death and elevated costimulatory molecules

Long, S., Zhao, Y., Xu, Y., Li, H., Zhao, H., Chen, D., Zeng, J., Qiu, H., Li, X., & Gu, Y. (2022) · Journal of Innovative Optical Health Sciences · doi:10.1142/s1793545822400028 · Cited by 6

Developing immunotherapeutic strategies to target brain tumors

Lieberman, N. A. P., Moyes, K. W., & Crane, C. A. (2016) · Expert Review of Anticancer Therapy · doi:10.1080/14737140.2016.1192470 · Cited by 6

The immuno-oncological implications of insulin

van Niekerk, G., Dalgleish, A. G., Joubert, F., Joubert, A. M., & Engelbrecht, A. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.118716 · Cited by 6

Combined blockade of VEGF, Angiopoietin-2, and PD1 reprograms glioblastoma endothelial cells into quasi-antigen-presenting cellsPreprint

Amoozgar, Z., Ren, J. P., Wang, N., Uccello, T. P., Andersson, P., Ferraro, G. B., Krishnan, S., Lei, P., Subudhi, S., Kawaguchi, K., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.09.03.506476 · Cited by 6

A Minireview on Nanosized Hypericin-Based Inducer of Immune Cell Death Under ROS-Based Therapies

Xu, C., Cai, X., & Du, L. (2025) · International Journal of Nanomedicine · doi:10.2147/ijn.s566489 · Cited by 5

Radiovaccination Strategy for Cancer Treatment Integrating Photodynamic Therapy-Generated Vaccines with Radiotherapy

Korbelik, M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232012263 · Cited by 5

A Novel Prognostic Marker and Therapeutic Target Associated with Glioma Progression in a Tumor Immune Microenvironment

Zhang, J.-J., Zhang, Y., Chen, Q., Chen, Q.-N., Yang, X., Zhu, X., Hao, C., & Duan, H. (2023) · Journal of Inflammation Research · doi:10.2147/jir.s398775 · Cited by 5

Drug-induced ciliogenesis in pancreatic cancer cells is facilitated by the secreted ATP-purinergic receptor signaling pathway

Khan, N. A., Garg, A. D., Agostinis, P., & Swinnen, J. V. (2017) · Oncotarget · doi:10.18632/oncotarget.23335 · Cited by 5

Far-Red Fluorescent Murine Glioma Model for Accurate Assessment of Brain Tumor Progression

Mishchenko, T. A., Владимировна, Б. И., Klimenko, M. O., Brilkina, A. A., Peskova, N. N., Guryev, E. L., Krysko, D. V., & Vedunova, M. V. (2022) · Cancers · doi:10.3390/cancers14153822 · Cited by 5

In vitro naphthylquinoxaline thymidine conjugate and UVA treated cancer cells are effective therapeutic vaccines for tumors in vivo with CpG as the adjuvant

Yang, R., Zhou, S., & Zhou, Q. (2021) · Journal of Advanced Research · doi:10.1016/j.jare.2021.03.003 · Cited by 4

Contributions of immune cell populations in the maintenance, progression, and therapeutic modalities of glioma

Caponegro, M. D., Miyauchi, J. T., & Tsirka, S. E. (2018) · AIMS Allergy and Immunology · doi:10.3934/allergy.2018.1.24 · Cited by 4

Functional characterization of tumor antigen-specific T-cells isolated from the tumor microenvironment of sleeping beauty induced murine glioma models

Alghamri, M. S., Núñez, F. J., Kamran, N., Carney, S. V., Altshuler, D. B., Lowenstein, P. R., & Castro, M. G. (2019) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/bs.mie.2019.05.032 · Cited by 4

Methods behind oncolytic virus-based DC vaccines in cancer: Toward a multiphase combined treatment strategy for Glioblastoma (GBM) patients

Gool, S. V., de Vliet, P. V., Kampers, L. F. C., Kosmal, J., Sprenger, T., Reich, E. D., Schirrmacher, V., & Stuecker, W. (2023) · Methods in cell biology · doi:10.1016/bs.mcb.2023.06.001 · Cited by 4

Immunotherapeutic strategies for treatment of hepatocellular carcinoma with antigen-loaded dendritic cells: in vivo study

El‐Ashmawy, N. E., El-Zamarany, E. A., Khedr, E. G., El‐Bahrawy, H. A., & El-Feky, O. A. (2018) · Clinical and Experimental Medicine · doi:10.1007/s10238-018-0521-6 · Cited by 4

Photodynamic Therapy in Cancer: Principles, State of the Art, and Future Directions

Krysko, D. V., Владимировна, Б. И., & Mishchenko, T. A. (2024) · Pharmaceutics · doi:10.3390/pharmaceutics16121564 · Cited by 4

Hypoxia-specific metal-organic frameworks combined with lactate immunometabolism regulation augment anti-tumor immunity of HIFU

Zhou, Y., Huang, X., Su, T., Su, K., Peng, S., & Li, H. (2025) · Materials Today Bio · doi:10.1016/j.mtbio.2025.102695 · Cited by 3

Distinct tumor immune microenvironmental landscapes drive divergent immunotherapy responses in glioblastoma

Weng, L., Gopalan, K. S., Guyot, M., Vanmechelen, M., Nazari, P., Duhamel, M., Donisi, C., Pallarés-Moratalla, C., Garg, A. D., White, K., et al. (2026) · Neuro-Oncology · doi:10.1093/neuonc/noag018 · Cited by 6

Trichosanthin-derived peptide Tk-PQ attenuates immune rejection in mouse tracheal allotransplant model by suppressing PI3K-Akt and inducing type II immune polarization

Zhou, L., Hou, Y., Pan, X., Wang, X. B., Jin, H., Yang, X., Wang, K., Ding, X., Wang, K., Zhu, M., et al. (2023) · International Immunopharmacology · doi:10.1016/j.intimp.2023.111081 · Cited by 3

Phospholipid scramblase 1 is involved in immunogenic cell death and contributes to dendritic cell–based vaccine efficiency to elicit antitumor immune response in vitro

Montico, B., Nigro, A., Lamberti, M. J., Martorelli, D., Mastorci, K., Ravo, M., Giurato, G., Steffan, A., Dolcetti, R., Casolaro, V., et al. (2023) · Cytotherapy · doi:10.1016/j.jcyt.2023.11.014 · Cited by 3

PDT and antitumor immunity: the beginnings of the story

Canti, G. L., & Rapozzi, V. (2024) · Photochemical & Photobiological Sciences · doi:10.1007/s43630-024-00627-1 · Cited by 5

Research and developments of laser assisted methods for translation into clinical application

Sroka, R. C., Dominik, N., Eisel, M., Esipova, A., Freymüller, C., Heckl, C., Hennig, G., Homann, C., Hoehne, N., Kammerer, R., et al. (2017) · Frontiers of Optoelectronics · doi:10.1007/s12200-017-0724-6 · Cited by 3

Bioinformatics analysis and validation of genes related to paclitaxel's anti-breast cancer effect through immunogenic cell death

Yang, Q., Yang, G., Wu, Y., Zhang, L., Song, Z., & Yang, D. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e28409 · Cited by 2

Cytofluorometric assessment of calreticulin exposure on CD38+ plasma cells from the human bone marrow

Beltrán‐Visiedo, M., del Valle, A. S., Jiménez‐Alduán, N., Soler-Agesta, R., Naval, J., Galluzzi, L., & Marzo, I. (2024) · Methods in cell biology · doi:10.1016/bs.mcb.2024.05.009 · Cited by 2

Molecular Subtyping and Therapeutic Targeting of IFNG ‐Driven Immunogenic Cell Death in Lung Adenocarcinoma

Li, L., Yang, Y., Peng, M., Wang, B., Zhu, L., Chen, C., Fan, Z., Duan, X., Xue, R., Lv, X., et al. (2025) · Cancer Medicine · doi:10.1002/cam4.70678 · Cited by 2

The role of ferroptosis in breast cancer: Tumor progression, immune microenvironment interactions and therapeutic interventions

Wang, Y., Tang, C., Wang, K., Zhang, X., Zhang, L., Xiao, X., Lin, H., & Xiong, L. (2025) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2025.177561 · Cited by 3

Nano-enabled combinatorial immunotherapy of colorectal cancer via small molecular PD-L1 blockade and photodynamic therapy

Zhang, J., Lu, T., Jia, R., Chen, Q., Wu, Y., Wang, Y., Ma, W., & Wang, Y. (2025) · Materials & Design · doi:10.1016/j.matdes.2025.115185 · Cited by 2

Photodynamic Therapy Combined with Anticancer Drug Therapy in the Treatment of Malignant Neoplasms

Reshetov, I. V., Alyasova, A., Shpileva, O., Karalkin, P. A., Efendiev, K. T., Pominova, D. V., Loschenov, V. B., Ilyasova, D., Agakina, Y. S., Gilyadova, A., et al. (2026) · Cells · doi:10.3390/cells15090781 · Cited by 2

Anti-PD1 antibody and not anti-LAG-3 antibody improves the antitumor effect of photodynamic therapy for treating metastatic breast cancer

Long, S., Zhao, Y., Xu, Y., Wang, B., Qiu, H., Zhao, H., Zeng, J., Chen, D., Li, H., Shao, J., et al. (2023) · Journal of Innovative Optical Health Sciences · doi:10.1142/s1793545823500207 · Cited by 2

The upregulation of immune checkpoints after photodynamic therapy reducing immune effect for treating breast cancer

Long, S., Wang, B., Cui, Y., Shao, J., Zhao, Y., Xu, Y., Li, H., Qiu, H., Zhao, H., Zeng, J., et al. (2023) · Lasers in Medical Science · doi:10.1007/s10103-023-03894-z · Cited by 2

Establishment of an orthotopic glioblastoma mouse model for preclinical studies

Iturrioz-Rodríguez, N., Piccardi, F., Bertorelli, R., & Ciofani, G. (2024) · Methods in cell biology · doi:10.1016/bs.mcb.2024.02.004 · Cited by 2

Inhibition of glioma development by doxorubicin-photochemical internalization generated macrophage vaccine: A survival study in rats

Nguyen, L., Christie, C., Madsen, S. J., Peng, Q., Berg, K., & Hirschberg, H. (2022) · Photodiagnosis and Photodynamic Therapy · doi:10.1016/j.pdpdt.2022.102879 · Cited by 2

HDAC inhibitor valproic acid increases CRABP2 expression and in combination with retinoic acid synergistically inhibits proliferation in glioblastoma cells

Yao, L. (2016) · doi:10.53846/goediss-6024 · Cited by 2

Mechanisms of triggering antitumor immunity: from photodynamic effects to immunogenic cell death

Sleptsova, E. E., Redkin, T. S., Saviuk, M. O., & Turubanova, V. D. (2024) · Genes and Cells · doi:10.17816/gc546129 · Cited by 1

Orientation of Preclinical Research in Ovarian Cancer

Baert, T., Garg, A. D., Agostinis, P., Vergote, I. B., & Coosemans, A. (2017) · International Journal of Gynecological Cancer · doi:10.1097/igc.0000000000001053 · Cited by 1

Engineered T Cells for glioblastoma therapy

Zhu, J., & Zhong, J. (2018) · Glioma · doi:10.4103/glioma.glioma_26_18 · Cited by 1

Antiangiogenic Therapy for Malignant Gliomas

Wang, N., Kloepper, J., Jain, R. K., & Batchelor, T. T. (2016) · Springer eBooks · doi:10.1007/978-3-319-49864-5_11

Remediação das vias p53/Arf e interferon-beta como uma estratégia de imunoterapia do câncer: uma abordagem de transferência gênica

Medrano, R. F. V. (2018) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.5.2018.tde-06042018-122815

Animal models of primary brain tumors

Kolb, B. L., Fadel, H. A., Klinger, N. V., & Mittal, S. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-814704-7.00007-6

Reassessing Twenty Years of Vaccine Development Against Tuberculosis

Schaible, U. E., & Kaufmann, S. H. E. (2018) · Frontiers research topics · doi:10.3389/978-2-88945-446-4 · Cited by 2

Peer Review #4 of "High expression of stromal signatures correlated with macrophage infiltration, angiogenesis and poor prognosis in glioma microenvironment (v0.2)"

(2020) · PeerJ · doi:10.7287/peerj.9038v0.2/reviews/4

Peer Review #4 of "High expression of stromal signatures correlated with macrophage infiltration, angiogenesis and poor prognosis in glioma microenvironment (v0.1)"

(2020) · PeerJ · doi:10.7287/peerj.9038v0.1/reviews/4

Reactive Oxygen Species, Central Regulators of the Tumor Microenvironment

Lamberti, M. J., Vera, R. E., Fernández-Zapico, M. E., & Vittar, N. B. R. (2021) · Springer eBooks · doi:10.1007/978-981-15-4501-6_159-1

Reactive Oxygen Species: Central Regulators of the Tumor Microenvironment

Lamberti, M. J., Vera, R. E., Fernández-Zapico, M. E., & Vittar, N. B. R. (2022) · Springer eBooks · doi:10.1007/978-981-15-9411-3_159

Cancer Immunology

Bekeschus, S., Pouvesle, J., Fridman, A., & Miller, V. (2018) · Springer eBooks · doi:10.1007/978-3-319-67627-2_24

Peer Review #2 of "High expression of stromal signatures correlated with macrophage infiltration, angiogenesis and poor prognosis in glioma microenvironment (v0.1)"

(2020) · PeerJ · doi:10.7287/peerj.9038v0.1/reviews/2

Peer Review #1 of "High expression of stromal signatures correlated with macrophage infiltration, angiogenesis and poor prognosis in glioma microenvironment (v0.1)"

(2020) · PeerJ · doi:10.7287/peerj.9038v0.1/reviews/1

Peer Review #3 of "High expression of stromal signatures correlated with macrophage infiltration, angiogenesis and poor prognosis in glioma microenvironment (v0.1)"

(2020) · PeerJ · doi:10.7287/peerj.9038v0.1/reviews/3

A Photodynamically Sensitized Dendritic Cell Vaccine that Promotes the Anti-Tumor effects of Anti-PD-L1 Monoclonal Antibody in Head and Neck Squamous Cell CarcinomaPreprint

Li, S., Wang, D., Cheng, J., Sun, J., Kalvakolanu, D. V., Zhao, X. B., Wang, D., You, Y., Zhang, L., & Yu, D. (2022) · Research Square · doi:10.21203/rs.3.rs-1718268/v1

CAR T cells and dendritic cells: vaccinomics perspectives

Anurogo, D. (2023) · International Physical Medicine & Rehabilitation Journal · doi:10.15406/ipmrj.2023.08.00347

Photodynamic Therapy and Applications in Cancer

Sarı, C., & Eyüpoğlu, F. C. (2023) · Recent advances in biotechnology · doi:10.2174/9789815179422123080007

CURRENT ACHIEVEMENTS OF DENDRITIC CELL-BASED IMMUNOTHERAPY

Džopalić, T., Topalović, M., & Bjelaković, M. (2019) · Acta Medica Medianae · doi:10.5633/amm.2019.0218

Development of smart optical nanoagents for cancer immunotheranostics

Xu, C. (2024) · DR-NTU (Nanyang Technological University) · doi:10.32657/10356/179290

Mechanism of Vaccine Development

Thorat, N. D. (2025) · Springer eBooks · doi:10.1007/978-3-031-86185-7_4

Photo- and Immunotherapy Interface: Can Dendritic Cell Vaccines Overcome the Limitations of PDT?

Shilyagina, N. Y., Sannova, Y., Turubanova, V. D., & Balalaeva, I. (2026) · Pharmaceutics · doi:10.3390/pharmaceutics18050588 · Cited by 1

Drug-eluting bead transarterial chemoembolization combined with immune checkpoint inhibitors is associated with improved progression-free survival in locally advanced or metastatic sarcoma: a retrospective propensity score-matched analysis

Zhou, C., Li, H., Qian, G., Yu, W., Zheng, S., Shen, Z., & Wang, Y. (2026) · Therapeutic Advances in Medical Oncology · doi:10.1177/17588359261450424

Checkpoint-insulated triple-signal artificial antigen-presenting cells drive antigen relay and systemic antitumor immunity

Zhao, S., Shi, T., Tian, T., Zhang, F., Zhang, Z., Xu, H., Zhou, Y., Li, Z., Qin, Z., Xu, P., et al. (2026) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2604171123

Pulsatilla saponin D triggers SHP2-mediated mitochondrial dysfunction and ferroptosis to augment cancer immunotherapy

Sun, C., Li, L., Dong, J., Wang, Y., Long, Y., Li, R., Yang, J., Liu, Y., Zhang, N., Liu, X., et al. (2026) · Phytomedicine · doi:10.1016/j.phymed.2026.158704

Dendritic cell vaccines for glioblastoma: Current progress and clinical challenges

Kanaan, M. H. G., Tarek, A. M., Beddai, A. A., Lee, B.-J., Abdullah, S. S., Park, C., & Ghasemian, A. (2026) · Vacunas · doi:10.1016/j.vacun.2026.500686

A Multiphase Combined Treatment Including Individualized Multimodal Immunotherapy and Tumor Microenvironment Therapy for Glioblastoma: A Decade of Experience with Real-World Patients

Kampers, L. F. C., Makalowski, J., de Vliet, P. V., & Gool, S. V. (2026) · Biomedicines · doi:10.3390/biomedicines14092044

Dataset related to article "Perioperative corticosteroid treatment impairs tumor-infiltrating dendritic cells in patients with newly diagnosed adult-type diffuse gliomas"

Carenza, C., Franzese, S., Castagna, A., Terzoli, S., Simonelli, M., Persico, P., Bello, L., Nibali, M. C., Pessina, F., Kunderfranco, P., et al. (2023) · Zenodo (CERN European Organization for Nuclear Research) · doi:10.5281/zenodo.10165863

Next-generation immunogenic dendritic cell vaccines achieve a danger signaling and T cell-driven eradication of high-grade glioma

Garg, A., Vandenberk, L., Koks, C., Verschuere, T., Gool, S. V., & Agostinis, P. (2016) · Klinische Pädiatrie · doi:10.1055/s-0036-1593558

Irradiation of necrotic tumor cells used to pulse dendritic cells (DCs) potentiates DC vaccine-induced anti-tumor immunity in a mouse model of high-grade glioma

Vandenberk, L., Garg, A. D., Agostinis, P., Verschuere, T., Koks, C., Vleeschouwer, S. D., & Gool, S. V. (2014) · Journal for ImmunoTherapy of Cancer · doi:10.1186/2051-1426-2-s3-p163 · Cited by 1

Targeting immunogenic cell death for glioma immunotherapy

Mishchenko, T. A., Turubanova, V. D., Gorshkova, E. N., Krysko, O., Vedunova, M. V., & Krysko, D. V. (2023) · Trends in cancer · doi:10.1016/j.trecan.2023.10.005 · Cited by 15

Immunogene op oxidatietherapie-gebaseerde tweede generatie dendritische celvaccins voor de behandeling van hooggradige gliomen

Vandenberk, L. (2016) · Lirias

Approaches to Improve Efficiency of Dendritic Cell-based Therapy of High Grade Gliomas

Chistiakov, D. A., Chekhonin, I. V., Gurina, O. I., Bobryshev, Y. V., & Chekhonin, V. P. (2016) · Current Pharmaceutical Design · doi:10.2174/1381612822666160719110618 · Cited by 7